Strong Revenue Growth
Q2 2025 revenue was $146 million, representing an 8% increase year-over-year and exceeding the high end of the guidance range.
EPS Increase
Earnings per share (EPS) for Q2 2025 was $0.24, up 20% year-over-year and above the midpoint of the guidance range.
Cash Flow Performance
Cash from operations was $36 million, exceeding the high end of the guidance range.
MedTech & Specialty Audio Segment Growth
Revenue for this segment was $67 million, up 13% sequentially and 10% year-over-year.
Precision Devices Segment Growth
Revenue for this segment was $79 million, up 8% sequentially and 6% year-over-year.
Bookings and Order Activity
Third consecutive quarter with positive bookings trends, with a book-to-bill ratio over 1.15 in the Precision Devices segment.
Share Repurchase Program
Repurchased $30 million in shares during Q2, funded by strong cash generation from operations.